Trial Profile
A Phase II Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects With Age-Related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2014
Price :
$35
*
At a glance
- Drugs Fenretinide (Primary)
- Indications Dry age-related macular degeneration
- Focus Therapeutic Use
- Sponsors Sirion Therapeutics
- 09 Jun 2014 New trial record